stretching, to modulate their protein interactions and downstream signaling. 48
Both extrinsic mechanical forces, acting on cadherins and integrins, and 49 intrinsic forces, generated by the actomyosin cytoskeleton, control epithelial 50 homeostasis, through the regulation of adhesion and barrier functions, cytoskeletal 51 organization, cell proliferation and morphogenesis [1] [2] [3] [4] [5] [6] . Mechanosensing proteins at 52 adherens and cell-substrate junctions respond to tension by changing their 53 conformation, leading to their enhanced association with actin filaments and actin-54 binding proteins, and mechanical strengthening of adhesion [7] [8] [9] [10] . Although the 55 polymerization and contractility of the cytoplasmic actomyosin cytoskeleton 56 modulates the nuclear shuttling of transcription factors [11] [12] [13] [14] , it is not clear whether the 57 circumferential actomyosin cytoskeleton associated with tight junctions can regulate 58 signaling by transcription factors. Furthermore, although actomyosin contractility 59 modulates TJ barrier function [15] [16] [17] , it is not known whether any TJ protein can 60 respond to tension by stretching and folding, and whether and how this could affect 61 barrier function. 62 ZO-1 and ZO-2 18, 19 are cytoplasmic components of TJ, and play a key role in 63 anchoring the junctional actomyosin cytoskeleton to TJ membrane proteins, through 64 the direct interaction of their C-terminal regions with actin filaments 15, 16 . The N-65 terminal moiety of ZO-1 and ZO-2 comprises three PDZ domains, followed by Src 66 homology-3 (SH3), U5, and guanylate kinase (GUK) domains 20 . The PDZ1 and 67 cells treated with control siRNA, and 104±7.4 nm in cells treated with control siRNA 102 and blebbistatin (Fig. 1h ). This indicates that the distance between the tags of 103 exogenous ZO-1 is not affected by tension in cells expressing ZO-2. The fluorescent 104 signals were also resolved in cells depleted of ZO-2, as long as they were not treated 105 with blebbistatin (Fig. 1e) , and the measured shift was 90±19 nm (Fig. 1g-h ). In 106 contrast, combining depletion of ZO-2 with blebbistatin treatment resulted in red and 107 green signals that were largely overlapped (Fig. 1f) , with a measured shift of 7.42 ±8 108 nm ( Fig. 1g-h ). This demonstrates that upon depletion of ZO-2 combined with 109 blebbistatin treatment, ZO-1 undergoes a conformational change, whereby the N-110 terminal and C-terminal ends come within a closer distance, which does not allow 111 resolution of the signals by SIM. This indicates that in the absence of ZO-2 112 actomyosin tension is required to maintain ZO-1 in a stretched conformation, and that 113 in the absence of tension ZO-1 undergoes intramolecular folding. Imaging of 114 multicolor microspheres (Fig. 1d) showed a technical chromatic shift in the xy plane 115 ranging from 15 ±13 nm at the center of the field to 55±7 nm at the edges of the field, 116 excluding the possibility the shifts observed between myc and HA tag signals were 117 artifacts. Taking this shift into account, our results indicate that when in the stretched 118 conformation, the length of ZO-1 is between 80 and 120 nm. 119
To confirm the tension-dependent changes in ZO-1 conformation, we used 120 PLA 37 to detect the physical proximity between myc and HA tags of exogeneous ZO-121 1, under the different experimental conditions (Fig. 1i-j) . Little or no PLA signal, 122 comparable to the negative control, was detected between myc and HA in the absence 123 of blebbistatin, regardless of the presence or depletion of ZO-2 (arrowheads in Fig. 1i , 124 myc+HA), indicating that the N-terminal and C-terminal regions of ZO-1 are > 30 nm 125 apart in the absence of blebbistatin. In contrast, in the presence of blebbistatin, the 126 PLA signal between myc and HA tags was dramatically increased upon depletion of 127 ZO-2, and was detectable both at cell-cell junctions, and in the cytoplasm of 128 overexpressing cells (arrows in Fig. 1j , myc+HA, si-ZO-2, and quantification in 129
The structured domains of ZO-1 are mechanically unfolded in vitro at forces > 136 5pN 137
138
To probe the mechanical stability of ZO-1, we purified recombinant, full-139 length ZO-1 from baculovirus-infected insect cells, and applied force to single 140 molecules, using magnetic tweezers 38, 39 (Fig. 2a) . When force was linearly increased 141 with a loading rate of 1 pN/s, the domains of ZO-1 were mechanically unfolded at 142 forces of 5-45 pN, as indicated by multiple extension steps (Fig. 2b, red and blue  143 curves). The unfolded domains of ZO-1 could be refolded at forces <5 pN, with a 144 loading rate of -0.3 pN/s (Fig. 2b, black curves, and inset) . These results suggest that 145 forces of several pN to tens of pN can cause unfolding of structured domains within 146 full-length ZO-1. Based on the step sizes of all the unfolding events, we estimate that 147 800-900 residues, which span about 50% of the full-length ZO-1 sequence, and likely 148 correspond to the N-terminal half of ZO-1, are in a stably folded conformation at 149 forces <5 pN. The rest of the molecule, lilely the C-terminal half of the molecule, is 150 either in an intrinsically disordered conformation, or mechanically too weak to be 151 determined in our experiments. Assuming that structured domains occupy half of the 152 residues in full-length ZO-1, and the other half is in a flexible disordered 153 conformation, we estimate that a force of ~ 2-4 pN is needed to maintain the stretched 154 conformation of ZO-1, with an N-to-C distance of ~100 nm, estimated on the basis of 155 SIM experiments (Fig. 1 ). This force is significantly smaller than that needed to 156 unfold the structured domains (> 5 pN, Fig. 1b) . 157
158
The stretched conformation of ZO proteins promotes the junctional localization of 159
DbpA and occludin in vivo 160 161
Next, we explored the biological consequences of ZO-1 stretching and 162 folding. ZO-1 and ZO-2 recruit the transcription factor DbpA and the transmembrane 163 protein occludin to TJ, by binding to them through its ZPSG (PDZ3-SH3-U5-GUK) 164 domain. We asked whether promoting the folded conformation of ZO-1, by depleting 165 cells of ZO-2 and treating them with blebbistatin, impacted on the junctional 166 accumulation of DbpA and occludin (Fig. 3) . In the absence of blebbistatin, DbpA 167 was detected at junctions both in WT cells, and in cells depleted of ZO-2 (arrows in 168 Fig. 3a) . However, upon treatment with blebbistatin, DbpA labeling was strongly 169 reduced at junctions of ZO-2-depleted cells (arrowheads in Fig. 3b , and quantification 170 in Fig. 3c ), but not WT cells (arrows in Fig. 3b , and quantification in Fig. 3c) . 171
Immunoblot analysis showed that DbpA levels were reduced in cells depleted of ZO-172 2 and treated with blebbistatin (red box in Fig. 3d ), phenocopying the proteolytic 173 degradation observed in ZO-1-KO cells depleted of ZO-2 36 . Similarly, junctional 174 labeling for occludin was normal in WT and ZO-2-KD cells in the absence of 175 blebbistatin (arrows in Fig. 3e ), but was dramatically reduced in the presence of 176 blebbistatin, only in ZO-2-KD cells (arrowheads in Fig. 3f ). Thus, experimental 177 conditions that lead to the folded conformation of ZO-1 (Fig. 1) protein, but not in WT cells (arrowheads in Supplementary Fig. 2b -BL) . 201
Phenocopying what was observed in cells depleted of both ZO proteins 36 , DbpA 202 protein levels were decreased in ZO-1-KO cells treated with blebbistatin (red box in 203 Supplementary Fig. 2c and quantification in Supplementary Fig. 2d ), and normal 204 DbpA levels were rescued by treatment with the proteasome inhibitor MG132 (green 205 box in Supplementary Fig. 2c and quantification in Supplementary Fig. 2d ), leading to 206 detection of DbpA in the cytoplasm and nucleus of ZO-1 KO cells ("n" in panel 207 BL/MG, Supplementary Fig. 2b ). Occludin was also localized at junctions of both 208
WT and ZO-1-KO cells (arrows in Supplementary Fig. 2e, control) , but, upon 209 treatment with blebbistatin, occludin labeling was decreased at junctions of ZO-1-KO, 210
but not WT cells (arrowheads in Supplementary Fig. 2e, BL) . Proximity ligation assay 211 (PLA) was used as an additional assay to detect proximity between ZO-1 and 212 occludin ( Supplementary Fig. 2f-g ). In the absence of blebbistatin, ZO-1 and occludin 213 were in close proximity, regardless of ZO-2 depletion (arrows in Supplementary Fig.  214 2f). However, in the presence of blebbistatin, ZO-1 was associated with occludin only 215 in the presence, but not in the absence of ZO-2 (arrows and arrowheads in 216 Supplementary Fig. 2g) . Supplementary Fig. 2b ) cell proliferation was increased, as 233 determined by labeling with Ki67, and this increase was reduced upon depletion of 234 DbpA ( Fig. 4a-b) . Under the same conditions, qRT-PCR showed increased expression 235 of the DbpA target genes cyclin D1 and PCNA (Fig. 4c ) and decreased expression of 236 ErbB2 (Fig. 4d) . These changes in gene expression did not occur in ZO-1-KO cells 237 treated with blebbistatin alone (Fig. 4c-d) , conditions under which DbpA is not 238 detected in the nucleus, and DbpA leves are reduced, due to proteasomal degradation 239 ( Supplementary Fig. 2b-c) . WT cysts (Fig. 5b,e) . In contrast, it rescued the stunted growth phenotype of ZO-1-271 KO cells, resulting in cyst growth and size similar to WT cells (Fig. 5d,e) . This 272 suggests that ZO-2 can be activated by stretching, induced by increased actomyosin 273 contractility. Immunoblotting showed that DbpA protein levels were reduced by about 274 80% in ZO-1-KO cysts, compared to WT, suggesting proteolytic degradation, and this 275 was rescued by treatment with dATP (red and green boxes in Fig. 5f ). 276
Immunofluorescence showed that in WT cells DbpA was localized in the nucleus at 277 early time points (Fig. 5g ), whereas at later stages it was localized at junctions (Fig.  278 5h), both in the presence and absence of dATP. In contrast, DbpA was undetectable 279
by immunofluorescence in ZO-1-KO cysts both at early ( Fig. 3b ), whereas all ZPSG regions interacted with GST-occludin 298 ( Supplementary Fig. 3c ). 299
Next, we focused on ZO-1 and ZO-2, and asked whether intramolecular 300 interactions between their ZPSG and C-terminal regions can occur, using GST 301 pulldown assays (Fig. 6 a-b for ZO-1 and Fig. 6c-d for ZO-2). Different constructs of 302 the C-terminal region of ZO-1 interacted with ZPSG-1, the strongest signal being 303 observed with the most C-terminal fragment of ZO-1 (1619-1748) (Fig. 6b) . 304
Similarly, the bacterially expressed C-terminal region of ZO-2 (890-1190) interacted 305 with the ZPSG-2 region (Fig. 6d) . 306
Next, we asked whether the interaction of the C-terminal region of ZO-1 with 307 ZPSG-1 inhibits the binding of ZPSG-1 to either DbpA or occludin. To this purpose, 308
we carried out competition GST pulldown assays, using HA-tagged DbpA as a prey, 309 either in the absence, or in the presence of increasing amounts of competing C-310
terminal fragments of ZO-1 (Fig. 6e-g ). The interaction of DbpA with ZPSG-1 was 311 not inhibited by GFP alone, but was inhibited by GFP-tagged fragments comprising 312 different regions of the C-terminal region of ZO-1, the most C-terminal fragment 313 (residues 1619-1748) being the most effective (Fig. 6e) Fig. 4g-j) . Similarly, DbpA but not CFP inhibited the interaction 320 between the ZPSG region of ZO-2 (ZPSG-2) and the C-terminal region of ZO-2 (890-321 1190) ( Supplementary Fig. 4d-f ). Competition pulldown assays were also carried out 322 usingt he C-terminal region of occludin as a prey (Fig. 6h-j) . The GFP-tagged C-323 terminal region of ZO-1 (1619-1748) (Fig. 6h ), but not GFP alone (Fig. 6i) inhibited 324 the interaction between ZPSG-1 and the C-terminal region of occludin. Taken 325 together, these data indicate that interactions between the C-terminal and ZPSG 326 domains within ZO proteins can inhibit binding of the ZPSG domains to DbpA and 327
occludin. 328
Full-length ZO-1 does not interact with GST-DbpA in pulldown assays 36 . 329
Since ZO-1 and ZO-2 form heterodimers through their PDZ2 domains 15, 26 , and 330 heterodimerization promotes the junctional localization of DbpA under low tension 331 conditions (Fig. 1, Fig. 3 ), we asked whether heterodimerization promotes the 332 interaction of full-length ZO-1 with DbpA in vitro. Using GST-DbpA as a bait, we 333 detected ZO-1 in pulldowns when increasing amounts of vsv-tagged full-length ZO-2 334 (Fig. 6k) , but not vsv-tagged p114-RhoGEF (negative control, (Fig. 7d) . If DbpA degradation is prevented by MG132, DbpA 361 can translocate into the nucleus, to regulate gene expression and promote proliferation 362 (Fig. 7d) . (Fig. 6b) . 584 presence of the proteasome inhibitor MG132, DbpA is not degraded, but is 614 translocated to the nucleus, where it regulates target gene transcription (Fig. 4a-b) . 
